|
Mr. James J. Mauzey joined the board of directors in May 2006 and is a member of the compensation committee.
Mr. Mauzey has over 30 years experience in the pharmaceutical industry. He was formerly president and chief executive officer of Bertek Pharmaceuticals, Inc, a division of Mylan Laboratories, Inc. Prior to that, he was chief executive officer of Innovex Worldwide, the contract sales division of Quintiles Transnational Organization and chairman and chief executive officer of Alteon Inc. In addition, Mr. Mauzey has held numerous sales, marketing and executive positions with Lederle Laboratories and Bristol-Myers Squibb Company. Mr. Mauzey received a bachelor’s degree from Lewis University and an MBA from Xavier University | 